Provided by Tiger Trade Technology Pte. Ltd.

Insulet

134.68
-3.2400-2.35%
Post-market: 134.790.1100+0.08%18:17 EDT
Volume:1.87M
Turnover:252.26M
Market Cap:9.33B
PE:25.43
High:138.66
Open:136.74
Low:134.11
Close:137.92
52wk High:354.88
52wk Low:126.40
Shares:69.26M
Float Shares:69.07M
Volume Ratio:1.22
T/O Rate:2.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.30
EPS(LYR):3.48
ROE:26.02%
ROA:9.71%
PB:6.56
PE(LYR):38.71

Loading ...

Insulet is Maintained at Neutral by Citigroup

Dow Jones
·
Jul 08

Citigroup Adjusts Insulet Price Target to $172 From $165

MT Newswires Live
·
Jul 08

Insulet price target raised to $172 from $165 at Citi

TIPRANKS
·
Jul 08

Citi Sticks to Their Hold Rating for Insulet (PODD)

TIPRANKS
·
Jul 08

Insulet Corp. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 07

Dexcom Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 07

Insulet is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Jul 07

Evercore ISI Adjusts Price Target on Insulet to $180 From $200

MT Newswires Live
·
Jul 06

Insulet Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 03

Insulet Files Form 3 Disclosing Jonathan Jay Mazelsky as Director Beneficial Owner

Reuters
·
Jul 03

Insulet Recalls Omnipod Pods After Insulin-Delivery Failure Risk Identified, FDA Says

MT Newswires Live
·
Jul 03

FDA says Insulet recalled certain Omnipod Pods

TIPRANKS
·
Jul 03

US FDA Classifies Insulet Omnipod Pods Recall as Class I Due to Serious Injury Risk

Reuters
·
Jul 03

US FDA - Insulet Reports 24 Serious Injuries, no Deaths from Omnipod Pods Issue as of May 20

THOMSON REUTERS
·
Jul 03

Insulet’s EVOLVE Trial Targets Big Type 2 Diabetes Opportunity With Omnipod M

TIPRANKS
·
Jul 03

Omnipod 6 vs. Omnipod 5: A Fresh Clinical Look at Insulet’s Next Growth Catalyst

TIPRANKS
·
Jul 03

Insulet’s Optimal-B Study: Real-World Omnipod 5 Data Investors Should Watch

TIPRANKS
·
Jul 03

Dexcom Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 02

Insulet to Report Q2 2026 Results, Host Conference Call

Reuters
·
Jul 01

Press Release: Insulet to Announce Second Quarter 2026 Financial Results on August 5, 2026

Dow Jones
·
Jul 01